呼吸内镜麻醉复苏期残余神经肌肉阻滞三例报告及文献复习
该文回顾性分析2024年清华大学附属垂杨柳医院3例呼吸内镜全麻术后复苏期不良事件,术中均使用0.1~0.2 mg/kg神经肌肉阻滞剂并于术后给予新斯的明拮抗,但3例均出现不良事件,文献复习提示残余阻滞可表现为胸闷、呼吸肌无力、低氧血症、呼吸衰竭及心力衰竭。
要点
- 呼吸内镜全麻复苏期残余神经肌肉阻滞可表现为胸闷、呼吸肌无力、低氧血症、呼吸衰竭和心力衰竭。
- 即使术后使用新斯的明拮抗,仍可能发生残余神经肌肉阻滞相关不良事件。
- 残余神经肌肉阻滞临床常见且危害严重,但尚未引起足够重视,需制订有效防范策略。
核心结论
- 残余神经肌肉阻滞的临床危害性尚未得到充分认识,需制订有效的防范策略以降低风险。
研究设计与样本
- 回顾性分析2024年清华大学附属垂杨柳医院3例全身麻醉下呼吸内镜治疗病例出现的不良事件。
- 检索Pubmed和万方数据库相关文献,总结分析残余神经肌肉阻滞的临床表现及风险。
主要发现
- 3例患者术中均注入神经肌肉阻滞剂顺阿曲库胺,用量为0.1~0.2 mg/kg,内镜手术操作顺利。
- 3例患者支气管镜操作结束后均给予新斯的明拮抗,但在麻醉复苏过程均出现不良事件。
- 第1例患者术后持续出现胸闷,各项辅助检查结果未见异常,心理测试考虑焦虑状态,心理干预后好转。
- 第2例患者出现呼吸衰竭、心力衰竭,积极抢救后转危为安;第3例患者麻醉恢复期出现长时间的低氧血症。
- 文献复习显示复苏期残余神经肌肉阻滞临床上可表现为胸闷、呼吸肌无力、低氧血症、呼吸衰竭、心力衰竭等。
临床怎么用
- 呼吸内镜全麻术后复苏期应警惕残余神经肌肉阻滞,关注胸闷、呼吸肌无力、低氧血症、呼吸衰竭和心力衰竭等表现。
局限性
- 本文为3例病例的回顾性分析,样本量小,结论需更大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the clinical risks and preventive strategies of residual neuromuscular blockade during the recovery period after general anesthesia for respiratory endoscopy. Methods: A retrospective analysis of 3 cases of respiratory endoscopy under intravenous general anesthesia was conducted at Chuiyangliu Hospital Affiliated to Tsinghua University in 2024. Relevant literature was searched in the Pubmed and Wanfang database to summarize and analyze the clinical manifestations and risks. Results: The 3 patients at our hospital underwent thorough evaluation before operation. Sedation and analgesia were administered, along with 0.1-0.2 mg/kg dose of the neuromuscular blocking agent succinylcholine. The bronchoscopy procedure was successful. Neostigmine was administered for antagonism after bronchoscopy in all 3 cases, but adverse events occurred during anesthesia recovery. The first patient experienced persistent chest tightness, despite normal results from auxiliary examination, and psychological testing suggested an anxiety state, which improved after psychological intervention. The second patient developed respiratory and heart failure but was successfully resuscitated. The third patient experienced prolonged hypoxemia during the recovery period from anesthesia. Literature analysis showed that residual neuromuscular block during the recovery period can manifest clinically as chest tightness, respiratory muscle weakness, hypoxemia, respiratory failure and heart failure. Residual neuromuscular block is common and causes severe adverse clinical effects. However, despite its serious clinical impact, residual neuromuscular block has not attracted much clinical attention. Conclusion: The clinical hazards associated with residual neuromuscular blockade are not widely recognized, and effective preventive strategies must be developed to mitigate these risks. 目的: 探究呼吸内镜全身麻醉术后复苏期残余神经肌肉阻滞的临床风险及防范策略。 方法: 回顾性分析2024年清华大学附属垂杨柳医院3例全身麻醉下呼吸内镜治疗病例出现的不良事件,检索Pubmed和万方数据库相关文献,总结分析残余神经肌肉阻滞的临床表现及风险。 结果: 3例患者术前均给予充分评估,术中在使用镇静镇痛同时均注入神经肌肉阻滞剂顺阿曲库胺,用量为 0.1~0.2 mg/kg,内镜手术操作顺利,3例患者支气管镜操作结束后均给予新斯的明拮抗,但在麻醉复苏过程均出现不良事件。第1例患者术后持续出现胸闷,各项辅助检查结果未见异常,心理测试考虑焦虑状态,心理干预后好转;第2例患者出现呼吸衰竭、心力衰竭,积极抢救后转危为安;第3例患者麻醉恢复期出现长时间的低氧血症。文献复习结果显示,复苏期残余神经肌肉阻滞临床上可表现为胸闷、呼吸肌无力、低氧血症、呼吸衰竭、心力衰竭等,且神经肌肉阻滞残余很常见,并对临床造成非常严重的不良影响。但残余神经肌肉阻滞对临床造成严重影响并没有引起临床足够重视。 结论: 残余神经肌肉阻滞的临床危害性尚未得到充分认识,需制订有效的防范策略以降低风险。.
引用
- Xue B, Zhou RR, Wu WJ, et al. [Residual neuromuscular blockade during recovery from anesthesia in respiratory endoscopy: a report of three cases and literature review]. Zhonghua Jie He He Hu Xi Za Zhi. 2025. PMID: 41073308. doi:10.3760/cma.j.cn112147-20250508-00252
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。